Location History:
- Ware, GB (1996 - 1998)
- Stevenage, GB (2012)
Company Filing History:
Years Active: 1996-2012
Title: The Innovations of Stephen John Skittrall
Introduction
Stephen John Skittrall is a notable inventor based in Ware, GB. He has made significant contributions to the field of pharmaceuticals, holding a total of 3 patents. His work primarily focuses on the development of novel compounds that have therapeutic applications.
Latest Patents
Skittrall's latest patents include a process for the preparation of 6-α,9-α-difluoro-17-α-((2-furanylcarbonyl)oxy)-11-β-hydroxy-16-α-methyl-3-oxo-androsta-1,4-diene-17-β-carbothioic acid S-fluoromethyl. This innovative process involves converting a compound of formula (II) to a compound of formula (I) via a compound of formula (III), or a salt thereof, without isolating any intermediates. Another significant patent relates to 3-[(2-(dimethylamino)ethyl]-N-methyl-1H-methanesulphonamide sulphate salt (2:1) and pharmaceutically acceptable solvates thereof. This compound is particularly useful in treating conditions associated with cephalic pain, especially migraines, and is designed for use in intranasal formulations.
Career Highlights
Stephen John Skittrall is currently associated with Glaxo Group Limited, where he continues to innovate and develop new pharmaceutical solutions. His work has been instrumental in advancing treatments for various medical conditions, showcasing his expertise in the field.
Collaborations
Skittrall has collaborated with notable colleagues such as Joanne Craig and Derek L Crookes. These partnerships have contributed to the successful development of his patented inventions.
Conclusion
Stephen John Skittrall's contributions to the pharmaceutical industry through his innovative patents highlight his role as a significant inventor. His work continues to impact the treatment of medical conditions, particularly in the realm of pain management.